TITLE

Micro-stents progressively defining their role in glaucoma management

AUTHOR(S)
Cimberle, Michela; Fox, Christi
PUB. DATE
July 2013
SOURCE
Ocular Surgery News;7/25/2013, Vol. 31 Issue 14, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the expanded role played by micro-stents in the management of glaucoma. It explains how micro-stents have helped fill a safety gap between medications and lasers and more traditional surgical procedures. It describes some safer procedures for management of glaucoma which are predicted to allow earlier interventions in patients noncompliant with medical therapy.
ACCESSION #
89393428

 

Related Articles

  • MIGS a promising opportunity for patients and physicians. Lindstrom, Richard L. // Ocular Surgery News;2/25/2012, Vol. 30 Issue 4, p5 

    The author reflects on the applicability of minimally invasive surgery and topical medications for glaucoma treatment. He notes that the removal of the natural lens with phacoemulsification and placement of an intraocular lens have proven to be quite effective in lowering elevated intraocular...

  • Stents reduce IOR drug burden. Krader, Cheryl Guttman; Chang, David F. // Ophthalmology Times;10/1/2012, Vol. 37 Issue 19, p32 

    The article offers information on a reduction of intraocular pressure and burden of drugs by the use of surgical stent. It states that implantation of two trabecular micro-bypass stents made by the U.S.-based Glaukos. Corp. with mild-to-moderate open-angle glaucoma supports the safety and...

  • MIGS, stents reduce drug burden. Krader, Cheryl Guttman; Samuelson, Thomas W. // Ophthalmology Times;12/15/2012, Vol. 37 Issue 24, p15 

    The article focuses on a study which provides information on the utility of the trabecular micro-bypass stent in managing advanced glaucoma. According to the study, microinvasive glaucoma surgery (MIGS) with ab interno implantation of two trabecular micro-bypass stents performed in conjunction...

  • FDA, AGS workshop yields consensus recommendations.  // Ocular Surgery News;4/10/2014, Vol. 32 Issue 7, p14 

    The article cites the consensus recommendations from panels of glaucoma specialists at the joint workshop of the American Glaucoma Society (AGS) and the U.S. Food and Drug Administration (FDA) regarding the clinical trials for minimally invasive glaucoma surgery (MIGS) devices.

  • NEW TECHNIQUES CENTERING ON CAPSULOTOMY CREATION. Guttman Krader, Cheryl // Ophthalmology Times;Dec2015, Vol. 40 Issue 20, p16 

    The article discusses advances in capsulotomy for cataract surgery in 2015. Topics discussed include an increase in the number of ophthalmologists using femtosecond laser-assisted cataract surgery (FLACS) in 2015, the launch of Mile High Ophthalmics' Verus Ophthalmic Caliper silicone ring to...

  • Microinvasive glaucoma surgery represents dawn of new era.  // Ocular Surgery News;4/10/2014, Vol. 32 Issue 7, p5 

    The article features some of the minimally invasive glaucoma surgery (MIGS) devices that will likely facilitate surgical treatment of glaucoma. Topics covered include the shift towards surgical procedures for intraocular pressure (IOP) control in glaucoma patients and the advantages of MIGS as...

  • Ab interno collagen stent enhances drainage to subconjunctival space. Hasson, Matt // Ocular Surgery News;9/10/2014, Vol. 32 Issue 17, p13 

    The article talks about a study by Richard A. Lewis and published in the "Journal of Cataract and Refractive Surgery" that reveals the viability of ab interno collagen stent as an alternative to other glaucoma drainage methods. Topics discussed include acqueous drainage, glaucoma implants, and...

  • Study: Suprachoroidal shunt with topical travoprost reduces IOP.  // Ocular Surgery News;4/10/2014, Vol. 32 Issue 7, p16 

    The article cites the early research findings reported by Dr. Jonathan S. Myers which suggest that implantation of iStent supra suprachoroidal micro-bypass stent from Glaukos with travoprost greatly lowers intraocular pressure (IOP) and medication burden in patients with open-angle glaucoma.

  • MIGS stent yields good IOP control as stand-alone treatment option. Caceres, Vanessa // Ophthalmology Times;Aug2015, Vol. 40 Issue 13, p14 

    The article discusses the Duette clinical trial for the CyPass micro-stent for glaucoma from medical device firm Transcend Medical led by ophthalmologist Quang H. Nguyen. The study reportedly involved several open-angle glaucoma patients refractory to drugs receiving CyPass as a stand-along...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics